| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |